Warning letter
Diamond Chemical Co., Inc.: warning letter of Sep 6, 2024
FDA warning letter 687078 · Division of Pharmaceutical Quality Operations I
Key facts
| Reference number | 687078 |
|---|---|
| Company | Diamond Chemical Co., Inc. |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Sep 6, 2024 |
| Posted date | Oct 1, 2024 |
| Issuing office | Division of Pharmaceutical Quality Operations I |
| Product type | Drugs |
| CFR sections cited | 211.84(d)(1), 211.100(a), 211.165(a), 211.166(a), 211.34 |
| Inspection city | East Rutherford |
| Inspection ZIP | 07073 |
| Inspection start date | May 6, 2024 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: